Komiya S

ORCID: 0000-0002-5587-7809 · 3 papers in corpus
other 2025
"Shortening time to pregnancy in infertile women by personalizing treatment of microbial imbalance through Emma & Alice: A multicenter prospective study"
Reproductive medicine and biology ·doi:10.1002/rmb2.12634

PURPOSE: To evaluate the impact of Endometrial Microbiome Metagenomic Analysis and Analysis of Infectious Chronic Endometritis (EMMA & ALICE) on pregnancy outcomes following recommended treatments in women with recurrent implantation failur…

other 2022
The novel oral gonadotropin-releasing hormone receptor antagonist relugolix is a new option for controlled ovarian stimulation cycles
Reproductive medicine and biology ·doi:10.1002/rmb2.12448

PURPOSE: Relugolix is an oral gonadotropin-releasing hormone antagonist (GnRHant), which was first introduced in 2019. This study investigated the effects of the conventional injectable GnRHant formulation and this new oral GnRHant formulat…

lab-animal 2020
Glucose transporter 1 is important for the glycolytic metabolism of human endometrial stromal cells in hypoxic environment
Heliyon ·doi:10.1016/j.heliyon.2020.e03985

AIM: The study aimed to elucidate the glycolytic metabolism of human endometrial stromal cells (hESCs) in hypoxic environment. MAIN METHODS: The hESCs were cultured in hypoxic environment, and their metabolic pathways were analyzed using m…